TP53 and sarcoma: Not only do elevated YAP and TAZ independently predict worse overall and progression-free survival, especially in the absence of p53 [92]; YAP’s upregulation of FOXM1 was found to be necessary for cell proliferation and tumorigenesis in a subset of sarcomas [91].